Show simple item record

dc.contributor.authorTolza, C
dc.contributor.authorBejjani, F
dc.contributor.authorEvanno, E
dc.contributor.authorMahfoud, S
dc.contributor.authorMoquet-Torcy, G
dc.contributor.authorGostan, T
dc.contributor.authorMaqbool, MA
dc.contributor.authorKirsh, O
dc.contributor.authorPiechaczyk, M
dc.contributor.authorJariel-Encontre, I
dc.date.accessioned2019-09-11T09:09:12Z
dc.date.available2019-09-11T09:09:12Z
dc.date.issued2019en
dc.identifier.citationTolza C, Bejjani F, Evanno E, Mahfoud S, Moquet-Torcy G, Gostan T, et al. AP-1 signaling by Fra-1 directly regulates HMGA1 oncogene transcription in triple negative breast cancers. Mol Cancer Res. 2019 Jul 12.en
dc.identifier.pmid31300541en
dc.identifier.doi10.1158/1541-7786.MCR-19-0036en
dc.identifier.urihttp://hdl.handle.net/10541/621987
dc.description.abstractThe architectural chromatin protein HMGA1 and the transcription factor Fra-1 are both overexpressed in aggressive Triple Negative Breast Cancers (TNBCs), where they both favor epithelial-to-mesenchymal transition, invasion and metastasis. We therefore explored the possibility that Fra-1 might be involved in enhanced transcription of the HMGA1 gene in TNBCs by exploiting cancer transcriptome data sets and resorting to functional studies combining RNA interference, mRNA- and transcriptional run-on assays, chromatin immunoprecipitation and chromosome conformation capture approaches in TNBC model cell lines. Our bioinformatic analysis indicated that Fra-1 and HMGA1 expressions positively correlate in primary samples of TNBC patients. Our functional studies showed that Fra-1 regulates HMGA1 mRNA expression at the transcriptional level via binding to enhancer elements located in the last two introns of the gene. Although Fra-1 binding is required for p300/CBP recruitment at the enhancer domain, this recruitment did not appear essential for Fra-1-stimulated HMGA1 gene expression. Strikingly, Fra-1 binding is required for efficient recruitment of RNA Polymerase II at the HMGA1 promoter. This is permitted owing to chromatin interactions bringing about the intragenic Fra-1-binding enhancers and the gene promoter region. Fra-1 is, however, not instrumental for chromatin loop formation at the HMGA1 locus but rather exerts its transcriptional activity by exploiting chromatin interactions preexisting to its binding. Implications: We demonstrate that Fra-1 bound to an intragenic enhancer region is required for RNA Pol II recruitement at the HMGA1 promoter. Thereby, we provide novel insights into the mechanisms whereby Fra-1 exerts its pro-oncogenic transcriptional actions in the TNBC pathological context.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1158/1541-7786.MCR-19-0036en
dc.titleAP-1 signaling by Fra-1 directly regulates HMGA1 oncogene transcription in triple negative breast cancersen
dc.typeArticleen
dc.contributor.departmentInstitut de Genetique Moleculaire de Montpellier, CNRS, University of Montpellieren
dc.identifier.journalMolecular Cancer Researchen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record